• Vincent Maher, Joe Gallagher, Ruth Agar, Damian Griffin, Niall Colwell, Patricia O'Connor, Brendan McAdam, Gerald Tomkin, Daphne Owens, Mary Ryan, William Tormey, and Maeve Durkan.
• ALMAR Centre, Tallaght University Hospital, Dublin 24, Ireland. vmaher@gmail.com.
• Ir J Med Sci. 2023 Oct 1; 192 (5): 215121572151-2157.

BackgroundLipid disorders are now considered causal for atherosclerotic cardiovascular disease (ASCVD) which remains one of the most important contributors to morbidity and mortality in the developed world. Identification and early treatment of lipid disarrays remains the cornerstone of good clinical practice to prevent, halt and even reverse ASCVD. Guidelines for lipid management are imperative to help promote good clinical practice. Given the detail involved in comprehensive guidelines and the multiple areas of knowledge required by clinical practitioners, abbreviated, easy to understand, practical versions of guidelines are required to ensure dissemination of the most important information. The recent ESC lipid guidelines 2019 and the ESC guidelines on CVD prevention in clinical practice 2021 (1,2), provide an excellent detailed summary of all the latest evidence supporting lipid interventions that reduce ASCVD.MethodWe therefore developed a single-page document with hyperlinks to help practitioners gain easy access to practical information on lipid management. It has been developed for future electronic use in clinical practice.ConclusionIt is presented here in a tabular format together with printable versions of the associated hyperlinks that provide the additional information required in decision making. It is hoped to audit the impact of this approach to help guide future ways of disseminating the latest clinical guideline updates.© 2023. The Author(s).

8 keywords...

hide…